Although several clinical studies reported that both 14-3-3β overexpression and HIF-1α are associated with the pathological characteristics and progression of various types of tumor [21, 32, 33], few study has reported the association between HIF-1α and 14-3-3β modulation in tumor progression and metastasis, notably in glioma. Here, HIF1A is linked to central nervous system cancer.